A new member of the insulin gene superfamily (INSL5) was identified by searching EST databases for the presence of the conserved insulin B-chain cysteine motif. Human and murine INSL5 are both polypeptides of 135 amino acids, matching the classical signature of the insulin superfamily. Through the B-and A-chain regions, human INSL5 has 48% identity to shark relaxin, 40% identity to human relaxin, and 34% identity to human Leydig insulin-like factor. Northern blot analysis detected expression of human INSL5 in rectal, colon, and uterine tissue and of murine INSL5 only in thymic tissue. Using quantitative RT-PCR, expression of murine INSL5 was detected in the highest quantity in colon followed by thymus, and minimal expression was seen in testis. By radiation hybrid mapping and the use of surrounding markers, human INSL5 maps to chromosome 1 in the 1p31.1 to 1p22.3 region. © 1999 Academic Press
INTRODUCTION
The insulin gene superfamily comprises a growing set of hormones that regulate cell growth, metabolism, and tissue-specific functions. Sequences in the superfamily are characterized by a signal peptide, a B-chain, a connecting C-chain, and an A-chain. As indicated by X-ray crystal structure analysis of insulin, IGF1, relaxin, and bombyxin, the B-and A-chains form a structural core of an amphipathic B-chain helix connected by two disulfide bonds to two short helices in the Achain. The A-chain contains one intrachain disulfide bond; therefore the total number of cysteines in the signature is 6. The spacing of the cysteine residues is conserved; this cysteine motif, the signal peptide, a conserved glycine at the N-terminus of the B-chain helix, and a few conserved hydrophobic residues packed into the protein interior together provide a signature for the classification of sequences into the insulin gene superfamily (Blundell and Humbel, 1980) . The insulin superfamily includes the vertebrate insulin (INS), insulin-like growth factor I (IGF1), insulinlike growth factor II (IGF2), relaxin (RLN1, RLN2), Leydig cell insulin-like protein (INSL3) (Adham et al., 1993) , early placenta insulin-like peptide (INSL4) (Chassin et al., 1995) , and a testis-derived relaxin-like factor referred to here as INSL6 (RRF; ZINS2) (Davis et al., 1997; Lok et al., 1998) . In addition, the family includes the insect hormone bombyxin, the locust and molluscan insulin-related peptides, and several recently discovered Caenorhabditis elegans insulin-like peptides (Duret et al., 1998) . Relaxins have also been described in sharks and skates (e.g., Bullesbach et al., 1986 , describe dogfish relaxin) but the function of relaxin in oviparous species is not yet known.
While the activity and function of insulin, IGF1, IGF2, and relaxin are well studied, the biological activities of the remaining vertebrate insulin superfamily members have not been conclusively demonstrated. Tissue localization of INSL3, INSL4, and INSL6 suggest a potential role in reproductive physiology (spermatogenesis, embryo implantation, fertilization capacity, sperm motility or parturition); however, the specific role of each hormone and the identification of their respective target cells and receptors await further study.
In this paper, we increase the membership of the vertebrate insulin gene superfamily by the cloning of a new insulin or relaxin-like hormone. Insulin-like peptide 5 (INSL5; 2 named ZINS3 in the patent application of Conklin et al., 1998) matches the classical signature of the insulin gene superfamily.
MATERIALS AND METHODS
Computational biology. To identify new members of the insulin gene superfamily, databases of human expressed sequence tags (ESTs) were searched using the tblastn program (Altschul et al., 1990) , in ungapped mode, scoring matrix BLOSUM62, and human relaxin (RLN1) as a query. All high-scoring segment pairs down to a score of 60 were retained and further inspected for the presence of Sequence data from this article have been deposited with the GenBank Data Library under Accession Nos. AF133816 and AF133817.
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To whom correspondence should be addressed. Telephone: (206) 442-6608. 2 The human gene symbol INSL5 has been approved by the HUGO Nomenclature Committee. The mouse gene symbol INSL5 has been approved by The Jackson Laboratory. the motif LCGXXhhXXXXXhC, where X denotes any residue except cysteine, and h denotes a hydrophobic residue. Propensity for signal peptide formation was predicted using the method of von Heijne (1986) . To identify the murine ortholog of INSL5, the full-length human INSL5 polypeptide and the tblastn program were used to search a mouse EST database for highly similar open reading frames.
Multiple-tissue Northern blots. A human INSL5 DNA fragment encompassing primarily the C-chain sequence was generated by PCR with forward primer 5Ј-TAG CTC CAG GTG GAG AAG GCA TCT-3Ј and reverse primer 5Ј-GGA ACA GCC ATC AGT GCA ACA CAA-3Ј from plasmid DNA containing full-length human INSL5. A mouse INSL5 DNA fragment encompassing all of the coding sequence for mouse INSL5 was generated by restriction digestion with EcoRI and NotI of DNA from Image Consortium clone 905403. Both DNA fragments were electrophoresed through a 1.5% agarose gel, recovered from the agarose using Qiaex II resin (Qiagen), and radioactively labeled using the Redi-Prime labeling system (Amersham), according to the manufacturers' instructions. The probe was purified using a Nuctrap push column (Stratagene). ExpressHyb (Clontech) was used as a prehybridization and hybridization buffer. The human Northern blots (Clontech) were probed with 2.5 ϫ 10 Ϫ6 cpm/ml at 55°C overnight, while the mouse multiple-tissue Northern blot (Origene) was probed with 2 ϫ 10 Ϫ6 cpm/ml at 50°C overnight. Both blots were washed at room temperature in 2ϫ SSC, 0.1% SDS, followed by a wash in 0.1ϫ SSC, 0.1% SDS at 65°C, and exposed to film for 3 (human) or 4 days (mouse).
Following INSL5 probing, the blots were stripped by boiling in 0.5% SDS and then were exposed to film to verify probe removal. The blots were then probed with mouse or human transferrin receptor probes to check blot quality. Transferrin receptor probes were generated by polymerase chain reaction (PCR), gel-purified, radioactively labeled as described above, and hybridized to the blots overnight at 55°C at a probe concentration of 1 ϫ 10 Ϫ6 cpm/ml. The blots were washed as described above and exposed to film for 2 days.
Total RNA extraction. RNA was prepared from snap-frozen tissue as follows. The tissues were weighed and processed according to mass using the RNeasy Midi Kit (Qiagen). Each tissue was ground in liquid nitrogen, and an appropriate volume of lysis buffer was added. 2-Mercaptoethanol was then added to form a concentration of 1% and the tissues were homogenized for 30 s using the OMNI Tissue Homogenizer (OMNI International). The homogenized tissues were prepared according to the manufacturer's specifications. Each RNA was electrophoresed on a 1% agarose gel in 1ϫ Tris-borate EDTA buffer to assess quality, and the concentrations were determined by reading a 1/50 dilution of the RNA samples on a Beckman DU640 spectrophotometer (Beckman). Samples were stored at Ϫ80°C.
Primers and probes for quantitative RT-PCR. Real-time quantitative RT-PCR using the ABI Prism 7700 Sequence Detection System (PE Applied Biosystems) has been previously described (Gibson et al., 1996; Heid et al., 1996; Sundaresan et al., 1998) . The primers and probes used for real-time quantitative RT-PCR analyses were designed using the primer design software Primer Express (PE Applied Biosystems). The primers and TaqMan probe for rodent glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were purchased from PE Applied Biosystems (TaqMan GAPDH control reagent kit). One of the primers for murine INSL5 was designed to span a predicted exon junction to eliminate amplification of genomic DNA. They were synthesized by Genset, and the corresponding INSL5 TaqMan probe was synthesized by PE Applied Biosystems. The GAPDH and INSL5 probes were labeled with a reporter fluorescent dye [2,7-dimethoxy-4,5-dichloro-6-carboxy-fluorescein (JOE) or 6-carboxy-fluorescein (FAM)], respectively, at the 5Ј-end and a quencher fluorescent dye (6-carboxy-tetramethyl-rhodamine) (TAMRA) at the 3Ј-end. Sequences for all primers and probes used in these analyses are shown in Table 1 .
In vitro transcription of RNA standard. Approximately 10 go f INSL5 insert in the vector pT7T3Dpac was cut with PvuII to liberate a 1128-bp fragment containing the gene of interest and the T7 promoter at the 5Ј-end of the sense strand. The fragment was phenol/ chloroform extracted, ethanol precipitated, and then transcribed using the Riboprobe System (Promega) according to the manufacturer's specifications. The transcription reaction mix was phenol/chloroform extracted and ethanol precipitated and the pellet was dissolved in Tris-EDTA and chromatographed on a NAP5 column (Pharmacia) to remove free nucleotides. Fractions containing transcript were pooled. The correct transcript size of ϳ956 bp was confirmed by agarose electrophoresis.
Real-time quantitative RT-PCR. Absolute levels of INSL5 RNA were determined by analysis of total RNA samples using the One-
Step RT-PCR method. An internal RNA standard was prepared by in vitro transcription of INSL5, which was then serially diluted in 50 ng/l of yeast tRNA and analyzed in triplicate in concentrations ranging from 1 ϫ 10 7 to 1 ϫ 10 2 molecules/reaction. Each total RNA sample was analyzed in triplicate for INSL5 transcript levels and for levels of the housekeeping gene GAPDH as an endogenous control using the protocol specified by PE Applied Biosystems. The relative efficiency of the two primer/probe sets was tested by serially diluting a single RNA sample for RT-PCR analysis and comparing the slopes derived from the resulting standard curves. The plot of log input versus DC T was Ͻ0.1, which passes the criterion established by PE Applied Biosystems (PE Applied Biosystems, 1997). The levels of INSL5 expression were first normalized to GAPDH expression and then absolute values were calculated based on the in vitro transcribed RNA standard curve.
Radiation hybrid mapping. INSL5 was mapped using the commercially available GeneBridge 4 radiation hybrid mapping panel (Research Genetics). The GeneBridge 4 panel contains PCR-amplifiable DNAs from each of 93 radiation hybrid clones, plus two control DNAs (the HFL donor and the A23 recipient). A publicly available WWW server (http://www-genome.wi.mit.edu/cgi-bin/contig/ rhmapper.pl) allows mapping relative to the Whitehead Institute/ MIT Center for Genome Research's radiation hybrid map of the human genome (the WICGR radiation hybrid map), which was constructed with the GeneBridge 4 panel. For the PCRs, INSL5 sequence-specific primers 5Ј-AAT CCA GCG CAA AAC C-3Ј and 5Ј-GGA ACA GCC ATC AGT G-3Ј were used. These primers yield a 153-bp PCR-amplified product from human genomic DNA. The correct sequence identity of this product was verified through sequencing. The data vector obtained with the GeneBridge 4 panel was 00001 00000 00100 01100 10100 01000 00100 00110 00001 11000 01000 00000 10100 00000 01011 00000 01000 11000 001.
YAC PCR. Four overlapping YAC clones (895B12, 930F4, 765B6, and 903C6) were obtained from Research Genetics and prepared as template for PCR following the supplier's recommendations. The YACs chosen included the short tandem repeat marker D1S198, the phosphodiesterase 4B gene (PDE4B), or the leptin receptor (LEPR) gene. The YACs were screened for the presence of INSL5 using the same primers and PCR conditions as in the radiation hybrid mapping. Reverse 5Ј-GGATGCAGGGATGATGTTC-3Ј Probe 5Ј-CAGAAGACTGTGGATGGCCCCTG-3Ј
RESULTS

Identification and Characterization of INSL5
Using the search procedure outlined under Materials and Methods, a novel human EST was found, at a score of 66 to human relaxin (RLN1), that contained a possible insulin B-chain motif. The cDNA library from which this DNA sequence was identified was generated from sigmoid colon tissue of a 40-year-old male with Crohn's disease. Inspection of the region 5Ј to the predicted Bchain region revealed a methionine followed by a segment strongly predicted to be a hydrophobic signal peptide. The complete insert of this clone was subsequently sequenced and revealed a 726-bp cDNA, containing a deduced 135-amino-acid polypeptide with a C-chain sequence and the conserved B-and A-chain cysteine motifs ( Fig. 1 ; GenBank Accession No. AF133816). A search of murine ESTs using this sequence revealed an EST, from a Barstead mouse irradiated colon library, with 56% amino acid identity to the human sequence. The complete insert of this clone was sequenced and revealed a 713-bp cDNA. This contained the deduced 135-amino-acid murine INSL5 polypeptide (GenBank Accession No. AF133817). The murine cDNA has an overall 67% identity to the human INSL5 cDNA, and its deduced polypeptide has an overall 59% identity to the human INSL5 polypeptide. A search with the full-length murine cDNA against mouse EST databases indicated a total of six matching ESTs: four from the Barstead mouse irradiated colon library, and two from the Soares 2NbMT (thymus) library.
In most members of the insulin superfamily, the C-chain is excised by prohormone convertases to produce the biologically active form of the hormone. The Through the B-and A-chain areas, human INSL5 has 71% identity to murine INSL5, 48% identity to shark (dogfish) relaxin, 40% identity to (human) relaxin, 34% to INSL3, 30% to insulin, 29% to INSL6, 29% to IGF2, 28% to IGF1, and 22% to INSL4. The 66-amino-acid C-chain of INSL5 has no detectable sequence similarity to the C-chain of other insulin family members, but has 48% identity to the 67-amino-acid C-chain of murine INSL5.
Northern Blot Analysis of Tissue Distribution of INSL5 Human Northern blot results revealed a restricted expression of human INSL5 transcript in the uterus and digestive tract. Levels of the 0.8-to 1.2-kb message were highest in rectum, with transcript also visible in ascending colon, descending colon, and uterus (Fig. 3 , left and middle). No transcript was apparent in additional blots that included mRNA from heart, brain, placenta, lung, liver, skeletal muscle, kidney, pancreas, stomach, thyroid, spinal cord, lymph node, adrenal gland, and bone marrow (data not shown).
Northern blot results for mouse INSL5 also revealed restricted expression, with a single transcript detectable only in thymus (Fig. 3, right) . No transcript was observed in additional blots that included mRNA from heart, brain, lung, skeletal muscle, kidney, and testis (data not shown).
Quantitative RT-PCR Analysis of Murine INSL5 Expression As discussed above, murine INSL5 message was detected in thymus (Northern blot analysis) and colon (EST data), and human Northern data suggested INSL5 expression in reproductive and gastrointestinal tissues. To explore the relative expression levels of INSL5 in murine thymus, colon, and uterus, the more sensitive method of quantitative RT-PCR for mRNA quantification was applied. Included in this assay was RNA from whole colon, subdivisions of the colon (midcolon and distal colon), thymus, ovary, and uterus from pregnant (Day 20) and nonpregnant mice and mouse testis. In addition, RNA from mouse pituitary and mouse liver was included. The highest expression of murine INSL5 was found to be in colon tissue with distal colon being the highest at Ͼ10 4 copies/ng of total RNA (Fig. 4) . Midcolon was slightly less followed by whole colon. Expression in thymus was ϳ10 3 copies/ng of total RNA, and there was minimal expression in the testis (ϳ50 copies/ng total RNA). Expression of INSL5 was not detectable in mouse ovary from either pregnant or nonpregnant mice or in mouse pituitary or liver.
Radiation Hybrid Mapping
The linkage analysis of the data vector for INSL5 showed that INSL5 maps 1.61 cR 3000 distal from the framework marker WI-7249 (D1S2393) on the chromosome 1 WICGR radiation hybrid map (LOD Ͼ 3.0). Proximal and distal framework markers were WI-7249 (D1S2393) and D1S198, respectively. Based on its distance from the framework marker WI-7249, INSL5 is 0.31 cR 3000 or approximately 83.7 kb proximal of the STRP marker D1S198, which has been shown to be significantly linked (P Ͻ 1 ϫ 10
Ϫ5
) to acute insulin response in Pima Indians (Thompson et al., 1995) . The use of surrounding markers positions INSL5 in the 1p31.1-1p22.3 region on the integrated LDB chromosome 1 map (The Genetic Location Database, University of Southhampton, WWW server: http://cedar. genetics.soton.ac.uk/public_html/). Thompson et al. (1997) constructed an approximately 9-Mb YAC contig surrounding the short tandem repeat marker D1S198, which shows linkage to AIR on chromosome 1. We chose four overlapping YACs (895B12, 930F4, 765B6, and 903C6) from that contig, which included the marker D1S198, the phosphodiesterase 4B (PDE4B) gene, or the leptin receptor (LEPR) gene. The PCR screening of the four YACs showed INSL5 to be located in the same YAC (765B6) and close to D1S198.
YAC Screening
DISCUSSION
By searching human EST databases for the presence of the conserved insulin superfamily B-chain cysteine motif, we have identified a novel family member, INSL5, and its murine ortholog. INSL5 matches the classical insulin superfamily signature, comprising a signal peptide, B-and A-chain cysteine motifs, and an intervening C-chain peptide. Through the B-and Achain regions, INSL5 shows the greatest similarity to the relaxins, specifically to shark (dogfish) relaxin. From an evolutionary perspective, this suggests that it is an ancient hormone whose ancestor dates back to the origin of sharks in the Devonian period.
In relaxin, Bullesbach and Schwabe (1988) have found that two arginines, at positions corresponding to Leu31 and Arg35 in INSL5, are strongly implicated in receptor binding. In the three-dimensional structure of relaxin (Eigenbrot et al., 1991) , the side chains of these two basic residues are pointing into the solvent and are separated by exactly one turn of the B-chain helix. It has been noted (Ivell, 1997) that INSL3 also contains the RXXXR cassette in the B-chain, although shifted in the C-terminal direction by four residues (one turn of the B-chain helix). The recently discovered INSL6 also has this cassette shifted by four residues, but with the arginines replaced by lysines. INSL5 and INSL6 contain one of the two arginines of the cassette; it is likely that this arginine is involved in receptor binding.
Numerous putative biological functions have been reported for relaxin including its involvement in pregnancy and birth, collagen remodeling, and smooth muscle relaxation. With the discovery of several novel members of the insulin superfamily, each with distinct tissue localization, it will be interesting to pinpoint more accurately the contributions of each of these proteins to functions perhaps inaccurately attributed to relaxin. As reported in a recent study (Zhao et al., 1999) , mice lacking a functional relaxin gene did not develop normal mammary gland or nipples, and pubic ligament relaxation did not occur. However, relaxin was not found to be necessary for maintaining pregnancy or for normal delivery in some animals. Confounding the issue is the fact that cell surface receptors for relaxin, INSL3, INSL4, INSL5, and INSL6, have not been identified. Binding sites for relaxin have been shown in tissues of the reproductive tract, mammary gland, cardiac atrium, and brain (Gunnersen et al., 1995; Kuenzi and Sherwood, 1995; Osheroff et al., 1997) . Whether the receptors for the relaxin-like molecules form a multigene family with specific binding patterns or whether there is promiscuity within the receptor family is unclear.
Our results indicate that the human INSL5 gene is localized proximal to the short tandem repeat marker D1S198 associated with acute insulin response. Recently, an approximately 9-Mb YAC contig surrounding D1S198 was constructed (Thompson et al., 1997) and searched for candidate genes. Both the phosphodiesterase 4B gene (PDE4B) and the leptin receptor gene (LEPR) were found in the 9-Mb contig proximal of D1S98 and suggested as possible candidate genes. At this time, however, no mutations in either of these genes has appeared in the literature in connection with acute insulin response. Our data indicate that INSL5 maps considerably closer to D1S198 than either LEPR or PDE4B. It will therefore be of interest to ascertain any INSL5 gene involvement in acute insulin response.
Relaxin is a multifunctional hormone involved in pregnancy, muscle contractility, and tissue remodeling. In this paper, we have reported on the identification of a novel relaxin-like molecule, INSL5. The absence of INSL5 message from ovarian tissues indicates a biological function distinct from relaxin and the other relaxin-like hormones. INSL5 is expressed at low levels in human uterus but is not detected by RT-PCR in mouse uterus, suggesting a difference in expression between the two species. The expression of INSL5 in the gastrointestinal tract and thymus suggests a potential role in gut contractility and thymic development and regulation. The presence of INSL5 message in the mouse thymus is consistent with other members of the insulin hormone superfamily. Insulin, IGF1, and IGF2 have previously been detected in the thymus and are believed to play a role in T-cell education or development (Burgess et al., 1999) . IGF1 is known to be an important growth factor for lymphocyte survival and regeneration (Hinton et al., 1998) while at least one role of insulin and IGF2 may be the need for thymic expression of proteins to permit self-antigen recognition (Geenen et al., 1999) . While no expression of INSL5 was detected in the human thymus by Northern blot analysis, the differences in thymic development, regulation, or involution between adult mice and humans may be responsible for the observed differences in expression. Further investigation of the effect of INSL5 protein on thymic development and regulation is needed to explain the differences observed in this study.
The discovery of the mouse expressed sequence tags from irradiated colon libraries suggests that INSL5 may have a role in the remodeling and repair of the gastrointestinal tract.
